The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CYCN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
ABUS · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
SIGY · Healthcare · No moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
| Measure | TFX | CYCN | ABUS | SIGY |
|---|---|---|---|---|
| Moat Score (0–100) | 33 (highest) | 33 (highest) | 33 (highest) | 33 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 20 | 33 | 53 (highest) | — |
| Pricing power | 89 (highest) | — | — | 80 |
| Returns on capital | 9 (highest) | 0 | 0 | 0 |
| Balance-sheet safety | 0 | 55 (highest) | 55 (highest) | 28 |
| Capital allocation | 47 (highest) | 44 | 24 | 24 |
| 15% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $5.8B | $13.4M | $843M | $48161 |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2024 |